Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	GRIP1 JARID2 FBXO38 MYBBP1A LDB1 SUN2 TSNARE1 GON4L SORBS1 RERE BRD1 PPP1R13L NIPBL MAML3 WWC1 DCAF12 NPAT	2.33e-07	1160	68	17	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	GRIP1 JARID2 FBXO38 MYBBP1A LDB1 SUN2 TSNARE1 GON4L SORBS1 RERE BRD1 PPP1R13L NIPBL MAML3 WWC1 DCAF12 NPAT	2.05e-06	1356	68	17	GO:0060090
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	1.51e-05	44	68	4	GO:0140938
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	8.50e-05	68	68	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	9.00e-05	69	68	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	1.01e-04	71	68	4	GO:0042054
GeneOntologyMolecularFunction	histone H3K36 trimethyltransferase activity	NSD2 ASH1L	1.14e-04	5	68	2	GO:0140955
GeneOntologyMolecularFunction	transcription coregulator activity	MYBBP1A LDB1 GON4L RERE PPP1R13L NIPBL MAML3 WWC1 NPAT	1.17e-04	562	68	9	GO:0003712
GeneOntologyMolecularFunction	transcription corepressor activity	MYBBP1A GON4L RERE PPP1R13L NIPBL NPAT	1.29e-04	229	68	6	GO:0003714
GeneOntologyMolecularFunction	protein methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	4.22e-04	103	68	4	GO:0008276
GeneOntologyMolecularFunction	N-methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	4.54e-04	105	68	4	GO:0008170
GeneOntologyMolecularFunction	microtubule binding	SUN2 MACF1 REEP3 DCX PSRC1 KIF3A	6.29e-04	308	68	6	GO:0008017
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	NSD2 ASH1L	8.70e-04	13	68	2	GO:0046975
GeneOntologyMolecularFunction	histone modifying activity	JARID2 NSD2 SETBP1 ASH1L BRD1	1.10e-03	229	68	5	GO:0140993
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETBP1 ASH1L	2.09e-03	20	68	2	GO:0042800
GeneOntologyMolecularFunction	S-adenosylmethionine-dependent methyltransferase activity	JARID2 NSD2 SETBP1 ASH1L	2.82e-03	172	68	4	GO:0008757
GeneOntologyBiologicalProcess	chromatin organization	HMGN5 JARID2 BPTF MYBBP1A NSD2 SETBP1 ASH1L MKI67 HLTF ZDBF2 RERE BRD1 UHRF2 TNP1 ZBTB1 NIPBL	1.97e-08	896	67	16	GO:0006325
GeneOntologyBiologicalProcess	chromatin remodeling	JARID2 BPTF MYBBP1A NSD2 SETBP1 ASH1L HLTF ZDBF2 RERE BRD1 UHRF2 TNP1 ZBTB1 NIPBL	8.84e-08	741	67	14	GO:0006338
GeneOntologyBiologicalProcess	protein-DNA complex organization	HMGN5 JARID2 BPTF MYBBP1A NSD2 SETBP1 ASH1L MKI67 HLTF ZDBF2 RERE BRD1 UHRF2 TNP1 ZBTB1 NIPBL	8.90e-08	999	67	16	GO:0071824
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	ORC2 JARID2 BPTF MYBBP1A MAGEL2 LDB1 NSD2 INPP5K GON4L PPARA RERE PPP1R13L TNP1 ZBTB1 NIPBL WWC1 NPAT	1.61e-06	1399	67	17	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	ORC2 JARID2 BPTF MYBBP1A MAGEL2 LDB1 NSD2 INPP5K GON4L PPARA RERE PPP1R13L TNP1 ZBTB1 NIPBL WWC1 NPAT	1.85e-06	1413	67	17	GO:1902679
GeneOntologyBiologicalProcess	tarsal gland development	ASH1L SCD5	3.11e-05	3	67	2	GO:1903699
GeneOntologyBiologicalProcess	regulation of developmental growth	JARID2 LPAR3 MYCBP2 MACF1 PPARA DCX NIPBL WWC1	6.41e-05	421	67	8	GO:0048638
GeneOntologyBiologicalProcess	uterus morphogenesis	ASH1L NIPBL	1.55e-04	6	67	2	GO:0061038
HumanPheno	Abnormal nipple morphology	GRIP1 JARID2 PNPLA6 NSD2 SETBP1 ASH1L RERE NIPBL	8.73e-06	254	23	8	HP:0004404
HumanPheno	Abnormal hair pattern	GRIP1 JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE PPP1R13L NIPBL CASZ1	9.05e-06	676	23	12	HP:0010720
HumanPheno	Abnormal eating behavior	MAGEL2 ASH1L RERE SRRM2 ATP10A CASZ1	1.59e-05	128	23	6	HP:0100738
HumanPheno	Restricted or repetitive behaviors or interests	JARID2 MAGEL2 NSD2 ASH1L PACS2 MACF1 RERE NIPBL CASZ1	1.60e-05	368	23	9	HP:0031432
HumanPheno	Perseverative thought	JARID2 MAGEL2 NSD2 ASH1L PACS2 MACF1 RERE NIPBL CASZ1	1.95e-05	377	23	9	HP:0030223
HumanPheno	Polyphagia	MAGEL2 RERE SRRM2 ATP10A CASZ1	2.01e-05	78	23	5	HP:0002591
HumanPheno	Abnormally increased volition	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX ATP10A NIPBL CASZ1	2.02e-05	869	23	13	HP:5200263
HumanPheno	Increased body weight	BPTF MAGEL2 PNPLA6 SETBP1 ASH1L RERE SRRM2 ATP10A NIPBL CASZ1	2.27e-05	491	23	10	HP:0004324
HumanPheno	Disordered formal thought process	JARID2 MAGEL2 NSD2 ASH1L PACS2 MACF1 RERE NIPBL CASZ1	2.36e-05	386	23	9	HP:0025769
HumanPheno	Abnormal thought pattern	JARID2 MAGEL2 NSD2 ASH1L PACS2 MACF1 RERE NIPBL CASZ1	3.40e-05	404	23	9	HP:5200269
HumanPheno	Hypoplasia of penis	GRIP1 MAGEL2 PNPLA6 SETBP1 RERE SRRM2 DCX NIPBL CASZ1	3.68e-05	408	23	9	HP:0008736
HumanPheno	Obesity	BPTF MAGEL2 PNPLA6 SETBP1 RERE SRRM2 ATP10A NIPBL CASZ1	5.10e-05	425	23	9	HP:0001513
HumanPheno	Disinhibition	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL CASZ1	5.72e-05	807	23	12	HP:0000734
HumanPheno	Inappropriate behavior	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL CASZ1	5.72e-05	807	23	12	HP:0000719
HumanPheno	Abnormal response to social norms	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL CASZ1	5.72e-05	807	23	12	HP:5200123
HumanPheno	Social disinhibition	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL CASZ1	5.72e-05	807	23	12	HP:5200029
HumanPheno	Abnormal female external genitalia morphology	GRIP1 MAGEL2 SETBP1 RERE NIPBL CASZ1	5.87e-05	161	23	6	HP:0000055
HumanPheno	Autistic behavior	JARID2 MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX NIPBL CASZ1	6.33e-05	678	23	11	HP:0000729
HumanPheno	Hyperactivity	JARID2 MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL	6.97e-05	558	23	10	HP:0000752
HumanPheno	Microcephaly	GRIP1 JARID2 BPTF PNPLA6 NSD2 INPP5K ASH1L PACS2 MACF1 RERE SRRM2 DCX ATP10A NIPBL CASZ1	1.00e-04	1341	23	15	HP:0000252
HumanPheno	Decreased head circumference	GRIP1 JARID2 BPTF PNPLA6 NSD2 INPP5K ASH1L PACS2 MACF1 RERE SRRM2 DCX ATP10A NIPBL CASZ1	1.13e-04	1354	23	15	HP:0040195
HumanPheno	Deeply set eye	JARID2 BPTF SETBP1 ASH1L RERE SRRM2 CASZ1	1.16e-04	266	23	7	HP:0000490
HumanPheno	Abnormal nasal bridge morphology	GRIP1 JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 MACF1 RERE PPP1R13L NIPBL CASZ1	1.30e-04	1029	23	13	HP:0000422
HumanPheno	Reduced impulse control	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX ATP10A NIPBL CASZ1	1.34e-04	1032	23	13	HP:5200045
HumanPheno	Depressed nasal bridge	GRIP1 JARID2 NSD2 SETBP1 ASH1L MACF1 RERE PPP1R13L NIPBL CASZ1	1.54e-04	612	23	10	HP:0005280
HumanPheno	Flattened nasal bridge	GRIP1 JARID2 NSD2 SETBP1 ASH1L MACF1 RERE PPP1R13L NIPBL CASZ1	1.54e-04	612	23	10	HP:0000425
HumanPheno	Diagnostic behavioral phenotype	JARID2 MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX NIPBL CASZ1	1.57e-04	747	23	11	HP:0025783
HumanPheno	Synophrys	JARID2 BPTF SETBP1 ASH1L PACS2 NIPBL	1.70e-04	195	23	6	HP:0000664
HumanPheno	Abnormal social development	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL CASZ1	1.88e-04	908	23	12	HP:0025732
HumanPheno	Small scrotum	GRIP1 MAGEL2 PNPLA6 SETBP1	1.89e-04	66	23	4	HP:0000046
HumanPheno	Hypermetropia	MAGEL2 SETBP1 ASH1L PACS2 RERE SRRM2 CASZ1	1.92e-04	288	23	7	HP:0000540
HumanPheno	Hypoplastic anterior commissure	MACF1 RERE	1.93e-04	5	23	2	HP:0030303
HumanPheno	Annular pancreas	SETBP1 RERE CASZ1	1.95e-04	26	23	3	HP:0001734
HumanPheno	Abnormal 5th finger morphology	JARID2 BPTF PNPLA6 NSD2 SETBP1 PACS2 RERE NIPBL CASZ1	2.10e-04	509	23	9	HP:0004207
HumanPheno	Hypoplastic male external genitalia	GRIP1 MAGEL2 PNPLA6 SETBP1 RERE SRRM2 DCX NIPBL CASZ1	2.26e-04	514	23	9	HP:0000050
HumanPheno	Facial hypertrichosis	JARID2 BPTF SETBP1 ASH1L PACS2 NIPBL	2.30e-04	206	23	6	HP:0002219
HumanPheno	Aggressive behavior	JARID2 BPTF MAGEL2 NSD2 SETBP1 PACS2 RERE NIPBL CASZ1	2.33e-04	516	23	9	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	JARID2 BPTF MAGEL2 NSD2 SETBP1 PACS2 RERE NIPBL CASZ1	2.33e-04	516	23	9	HP:0006919
HumanPheno	Cryptorchidism	GRIP1 MAGEL2 PNPLA6 MYLK NSD2 SETBP1 ASH1L PACS2 RERE NIPBL CASZ1	2.33e-04	780	23	11	HP:0000028
HumanPheno	Abnormal palm morphology	JARID2 MAGEL2 PNPLA6 NSD2 SETBP1 RERE PPP1R13L SRRM2 NIPBL	2.51e-04	521	23	9	HP:0100871
HumanPheno	Abnormality of the chin	JARID2 MAGEL2 NSD2 SETBP1 RERE SRRM2 ATP10A CASZ1	2.69e-04	409	23	8	HP:0000306
HumanPheno	Abnormal location of ears	GRIP1 JARID2 MAGEL2 PNPLA6 NSD2 SETBP1 ASH1L MACF1 RERE SRRM2 NIPBL CASZ1	2.79e-04	945	23	12	HP:0000357
HumanPheno	Single transverse palmar crease	JARID2 PNPLA6 NSD2 SETBP1 RERE NIPBL	2.91e-04	215	23	6	HP:0000954
HumanPheno	Abnormality of the frontal hairline	JARID2 NSD2 ASH1L RERE PPP1R13L NIPBL	2.91e-04	215	23	6	HP:0000599
HumanPheno	Deviation of finger	BPTF MAGEL2 PNPLA6 NSD2 SETBP1 PACS2 RERE NIPBL CASZ1	3.16e-04	537	23	9	HP:0004097
HumanPheno	Recurrent maladaptive behavior	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 MACF1 RERE SRRM2 DCX ATP10A NIPBL CASZ1	3.25e-04	1293	23	14	HP:5200241
HumanPheno	High anterior hairline	JARID2 NSD2 RERE PPP1R13L	3.27e-04	76	23	4	HP:0009890
HumanPheno	Abnormality of globe location	GRIP1 JARID2 BPTF MYLK NSD2 SETBP1 ASH1L PACS2 MACF1 RERE SRRM2 NIPBL CASZ1	3.28e-04	1122	23	13	HP:0100886
HumanPheno	Abnormal eyebrow morphology	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE NIPBL CASZ1	3.47e-04	674	23	10	HP:0000534
HumanPheno	External genital hypoplasia	GRIP1 MAGEL2 PNPLA6 SETBP1 RERE SRRM2 DCX NIPBL CASZ1	3.49e-04	544	23	9	HP:0003241
HumanPheno	Hypertrichosis	JARID2 BPTF SETBP1 ASH1L PACS2 RERE NIPBL CASZ1	3.51e-04	425	23	8	HP:0000998
HumanPheno	Abnormal scrotum morphology	GRIP1 MAGEL2 PNPLA6 SETBP1 SRRM2	3.64e-04	143	23	5	HP:0000045
HumanPheno	Impairment in personality functioning	JARID2 BPTF MAGEL2 PNPLA6 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 ATP10A NIPBL CASZ1	3.91e-04	1141	23	13	HP:0031466
HumanPheno	Abnormal upper lip morphology	GRIP1 JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 NIPBL CASZ1	3.98e-04	980	23	12	HP:0000177
HumanPheno	Medial flaring of the eyebrow	JARID2 BPTF SETBP1 ASH1L PACS2 NIPBL	4.00e-04	228	23	6	HP:0010747
HumanPheno	Abnormality of the anterior commissure	MACF1 RERE	4.04e-04	7	23	2	HP:0030301
HumanPheno	Congenital abnormal hair pattern	JARID2 MAGEL2 NSD2 ASH1L RERE PPP1R13L NIPBL	4.21e-04	327	23	7	HP:0011361
HumanPheno	Abnormal breast morphology	GRIP1 JARID2 PNPLA6 NSD2 SETBP1 ASH1L RERE NIPBL	4.52e-04	441	23	8	HP:0031093
HumanPheno	Deviation of the hand or of fingers of the hand	BPTF MAGEL2 PNPLA6 NSD2 SETBP1 PACS2 RERE NIPBL CASZ1	4.58e-04	564	23	9	HP:0009484
HumanPheno	Strabismus	BPTF MAGEL2 PNPLA6 NSD2 INPP5K SETBP1 ASH1L PACS2 MACF1 RERE SRRM2 NIPBL CASZ1	4.60e-04	1159	23	13	HP:0000486
HumanPheno	Abnormality of the breast	GRIP1 JARID2 PNPLA6 NSD2 SETBP1 ASH1L RERE NIPBL	4.95e-04	447	23	8	HP:0000769
HumanPheno	Feeding difficulties	BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 MACF1 RERE SRRM2 DCX ATP10A NIPBL CASZ1	4.99e-04	1168	23	13	HP:0011968
HumanPheno	Radial deviation of finger	BPTF MAGEL2 PNPLA6 NSD2 PACS2 RERE NIPBL CASZ1	5.03e-04	448	23	8	HP:0009466
HumanPheno	Cleft lip	GRIP1 JARID2 NSD2 RERE PPP1R13L NIPBL	5.27e-04	240	23	6	HP:0410030
HumanPheno	Abnormality of refraction	BPTF MAGEL2 PNPLA6 SETBP1 ASH1L PACS2 RERE SRRM2 NIPBL CASZ1	5.27e-04	709	23	10	HP:0000539
HumanPheno	Abnormal penis morphology	GRIP1 MAGEL2 PNPLA6 NSD2 SETBP1 RERE SRRM2 DCX NIPBL CASZ1	5.46e-04	712	23	10	HP:0000036
HumanPheno	Radial deviation of the hand or of fingers of the hand	BPTF MAGEL2 PNPLA6 NSD2 PACS2 RERE NIPBL CASZ1	5.67e-04	456	23	8	HP:0009485
HumanPheno	Hip dysplasia	MAGEL2 NSD2 SETBP1 RERE NIPBL CASZ1	6.14e-04	247	23	6	HP:0001385
HumanPheno	Abnormality of the philtrum	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L RERE SRRM2 NIPBL CASZ1	6.40e-04	726	23	10	HP:0000288
HumanPheno	Abnormal conjugate eye movement	BPTF MAGEL2 PNPLA6 NSD2 INPP5K SETBP1 ASH1L PACS2 MACF1 RERE SRRM2 NIPBL CASZ1	6.49e-04	1198	23	13	HP:0000549
HumanPheno	Abnormality of the palmar creases	JARID2 PNPLA6 NSD2 SETBP1 RERE NIPBL	8.07e-04	260	23	6	HP:0010490
HumanPheno	Abnormal palmar dermatoglyphics	JARID2 PNPLA6 NSD2 SETBP1 RERE NIPBL	8.92e-04	265	23	6	HP:0001018
HumanPheno	Abnormal hair morphology	GRIP1 JARID2 BPTF MAGEL2 PNPLA6 NSD2 SETBP1 ASH1L PACS2 RERE PPP1R13L ATP10A NIPBL CASZ1	9.53e-04	1424	23	14	HP:0001595
HumanPheno	Abnormality of globe location or size	GRIP1 JARID2 BPTF MYLK NSD2 SETBP1 ASH1L PACS2 MACF1 RERE SRRM2 NIPBL CASZ1	9.71e-04	1246	23	13	HP:0000489
HumanPheno	Abnormal lip morphology	GRIP1 JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE PPP1R13L SRRM2 NIPBL CASZ1	9.95e-04	1249	23	13	HP:0000159
HumanPheno	Abnormal pubic bone morphology	GRIP1 NSD2 SETBP1	1.01e-03	45	23	3	HP:0003172
HumanPheno	Decreased Achilles reflex	FBXO38 PNPLA6	1.05e-03	11	23	2	HP:0009072
HumanPheno	Downturned corners of mouth	MAGEL2 NSD2 ASH1L PACS2 NIPBL	1.10e-03	182	23	5	HP:0002714
HumanPheno	Abnormal motivation	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX ATP10A NIPBL CASZ1	1.11e-03	1263	23	13	HP:5200275
HumanPheno	Abnormal volitional state	JARID2 BPTF MAGEL2 NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX ATP10A NIPBL CASZ1	1.11e-03	1263	23	13	HP:0025780
HumanPheno	Motor stereotypy	NSD2 ASH1L PACS2 MACF1 RERE CASZ1	1.19e-03	280	23	6	HP:0000733
HumanPheno	Rib fusion	NSD2 RERE CASZ1	1.22e-03	48	23	3	HP:0000902
HumanPheno	Short attention span	JARID2 MAGEL2 SETBP1 PACS2 RERE SRRM2 ATP10A NIPBL	1.31e-03	517	23	8	HP:0000736
HumanPheno	Displacement of the urethral meatus	GRIP1 PNPLA6 NSD2 SETBP1 RERE NIPBL CASZ1	1.35e-03	397	23	7	HP:0100627
HumanPheno	Abnormal male urethral meatus morphology	GRIP1 PNPLA6 NSD2 SETBP1 RERE NIPBL CASZ1	1.39e-03	399	23	7	HP:0032076
HumanPheno	Reduced attention regulation	JARID2 MAGEL2 SETBP1 PACS2 RERE SRRM2 ATP10A NIPBL	1.47e-03	526	23	8	HP:5200044
HumanPheno	Short sternum	SETBP1 NIPBL	1.48e-03	13	23	2	HP:0000879
HumanPheno	Abnormal pinna morphology	GRIP1 JARID2 BPTF MAGEL2 PNPLA6 NSD2 SETBP1 ASH1L MACF1 RERE SRRM2 NIPBL CASZ1	1.48e-03	1299	23	13	HP:0000377
HumanPheno	Microtia	GRIP1 BPTF NSD2 RERE CASZ1	1.50e-03	195	23	5	HP:0008551
HumanPheno	Abnormality of mouth shape	MAGEL2 NSD2 SETBP1 ASH1L PACS2 NIPBL	1.54e-03	294	23	6	HP:0011338
HumanPheno	Abnormality of the hairline	JARID2 NSD2 ASH1L RERE PPP1R13L NIPBL	1.54e-03	294	23	6	HP:0009553
HumanPheno	Brachydactyly	GRIP1 BPTF MAGEL2 PNPLA6 NSD2 SETBP1 RERE NIPBL CASZ1	1.63e-03	670	23	9	HP:0001156
HumanPheno	Aplasia/Hypoplasia involving bones of the feet	GRIP1 MAGEL2 NSD2 RERE NIPBL CASZ1	1.65e-03	298	23	6	HP:0006494
HumanPheno	Short digit	GRIP1 BPTF MAGEL2 PNPLA6 NSD2 SETBP1 RERE NIPBL CASZ1	1.67e-03	672	23	9	HP:0011927
HumanPheno	Abnormal consumption behavior	MAGEL2 ASH1L RERE SRRM2 ATP10A CASZ1	1.68e-03	299	23	6	HP:0040202
HumanPheno	Attention deficit hyperactivity disorder	JARID2 MAGEL2 SETBP1 PACS2 RERE SRRM2 NIPBL	1.71e-03	413	23	7	HP:0007018
HumanPheno	Abnormal skin morphology of the palm	JARID2 PNPLA6 NSD2 SETBP1 RERE PPP1R13L NIPBL	1.71e-03	413	23	7	HP:0040211
HumanPheno	Syndactyly	GRIP1 JARID2 MAGEL2 PNPLA6 SETBP1 RERE NIPBL	1.81e-03	417	23	7	HP:0001159
HumanPheno	Abnormal male external genitalia morphology	GRIP1 MAGEL2 PNPLA6 MYLK NSD2 SETBP1 ASH1L PACS2 RERE SRRM2 DCX NIPBL CASZ1	1.86e-03	1329	23	13	HP:0000032
HumanPheno	Hypertelorism	GRIP1 JARID2 BPTF MYLK NSD2 SETBP1 ASH1L PACS2 MACF1 RERE	1.87e-03	830	23	10	HP:0000316
Domain	PHD	BPTF NSD2 ASH1L BRD1 UHRF2	7.26e-06	75	67	5	PF00628
Domain	Znf_PHD-finger	BPTF NSD2 ASH1L BRD1 UHRF2	9.37e-06	79	67	5	IPR019787
Domain	PHD	BPTF NSD2 ASH1L BRD1 UHRF2	1.68e-05	89	67	5	SM00249
Domain	Znf_PHD	BPTF NSD2 ASH1L BRD1 UHRF2	1.87e-05	91	67	5	IPR001965
Domain	ZF_PHD_2	BPTF NSD2 ASH1L BRD1 UHRF2	2.30e-05	95	67	5	PS50016
Domain	ZF_PHD_1	BPTF NSD2 ASH1L BRD1 UHRF2	2.42e-05	96	67	5	PS01359
Domain	Zinc_finger_PHD-type_CS	BPTF NSD2 ASH1L BRD1	8.69e-05	65	67	4	IPR019786
Domain	AWS	NSD2 ASH1L	1.26e-04	5	67	2	SM00570
Domain	AWS	NSD2 ASH1L	1.26e-04	5	67	2	PS51215
Domain	AWS_dom	NSD2 ASH1L	1.26e-04	5	67	2	IPR006560
Domain	Znf_FYVE_PHD	BPTF NSD2 ASH1L BRD1 UHRF2	1.84e-04	147	67	5	IPR011011
Domain	BROMODOMAIN_1	BPTF ASH1L BRD1	3.14e-04	37	67	3	PS00633
Domain	Bromodomain	BPTF ASH1L BRD1	3.40e-04	38	67	3	PF00439
Domain	BROMODOMAIN_2	BPTF ASH1L BRD1	4.27e-04	41	67	3	PS50014
Domain	BROMO	BPTF ASH1L BRD1	4.58e-04	42	67	3	SM00297
Domain	Bromodomain	BPTF ASH1L BRD1	4.58e-04	42	67	3	IPR001487
Domain	-	BPTF ASH1L BRD1	4.58e-04	42	67	3	1.20.920.10
Domain	BAH	ASH1L RERE	6.83e-04	11	67	2	SM00439
Domain	BAH	ASH1L RERE	6.83e-04	11	67	2	PF01426
Domain	BAH	ASH1L RERE	6.83e-04	11	67	2	PS51038
Domain	BAH_dom	ASH1L RERE	6.83e-04	11	67	2	IPR001025
Domain	-	BPTF MYCBP2 NSD2 ASH1L HLTF BRD1 UHRF2	1.11e-03	449	67	7	3.30.40.10
Domain	Znf_RING/FYVE/PHD	BPTF MYCBP2 NSD2 ASH1L HLTF BRD1 UHRF2	1.26e-03	459	67	7	IPR013083
Domain	Post-SET_dom	NSD2 ASH1L	1.47e-03	16	67	2	IPR003616
Domain	PostSET	NSD2 ASH1L	1.47e-03	16	67	2	SM00508
Domain	POST_SET	NSD2 ASH1L	1.47e-03	16	67	2	PS50868
Domain	PWWP	NSD2 BRD1	2.31e-03	20	67	2	SM00293
Domain	SH3_9	MYO1F SORBS1 PPP1R13L	2.77e-03	78	67	3	PF14604
Domain	PWWP	NSD2 BRD1	3.06e-03	23	67	2	PF00855
Domain	PWWP_dom	NSD2 BRD1	3.06e-03	23	67	2	IPR000313
Domain	PWWP	NSD2 BRD1	3.33e-03	24	67	2	PS50812
Domain	Bromodomain_CS	BPTF BRD1	3.90e-03	26	67	2	IPR018359
Domain	AT_hook	SETBP1 ASH1L	4.20e-03	27	67	2	SM00384
Domain	AT_hook_DNA-bd_motif	SETBP1 ASH1L	4.20e-03	27	67	2	IPR017956
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	HMGN5 ORC2 FBXO38 BPTF NSD2 MKI67 HLTF BRD1 UHRF2 NIPBL CASZ1 SENP7 KNOP1 NPAT	1.37e-11	608	69	14	36089195
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BPTF LPAR3 PNPLA6 LDB1 MYCBP2 NSD2 TSNARE1 SETBP1 ASH1L LARP1 MACF1 GREB1 PPARA RERE REEP3 ATP10A MAML3 CASZ1	4.55e-10	1489	69	18	28611215
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FBXO38 BPTF MYBBP1A GBF1 PNPLA6 MYCBP2 MKI67 LARP1 PACS2 RERE SRRM2 NIPBL SYMPK	3.65e-09	774	69	13	15302935
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	BPTF MYBBP1A NSD2 MKI67 UHRF2 NIPBL	2.03e-08	86	69	6	37253089
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	JARID2 BPTF SUN2 SORBS1 RERE BRD1 REEP3 NIPBL WWC1 SYMPK	1.05e-07	536	69	10	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	JARID2 BPTF SUN2 SORBS1 RERE BRD1 REEP3 NIPBL WWC1 SYMPK	1.08e-07	538	69	10	10512203
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	BPTF PNPLA6 NSD2 SUN2 INPP5K ASH1L MACF1 RERE BRD1 SRRM2 WWC1 SENP7 KNOP1	2.60e-07	1116	69	13	31753913
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	MKI67 SRRM2 NIPBL NPAT	3.25e-07	29	69	4	17577209
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ORC2 BPTF MYBBP1A NSD2 MKI67 LARP1 ZDBF2 SRRM2 NIPBL KNOP1 SYMPK NPAT	3.55e-07	954	69	12	36373674
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ORC2 BPTF MYBBP1A SUN2 MKI67 GREB1 SRRM2 SYMPK	3.91e-07	341	69	8	32971831
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BPTF MYBBP1A MYCBP2 NSD2 MKI67 LARP1 MACF1 SRRM2 NIPBL SYMPK	6.38e-07	653	69	10	22586326
Pubmed	Transcription factors expressed in olfactory bulb local progenitor cells revealed by genome-wide transcriptome profiling.	HMGN5 ORC2 MYBBP1A NSD2 MKI67	1.08e-06	91	69	5	21194568
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ORC2 JARID2 MYBBP1A LDB1 ASH1L HLTF PPARA RERE BRD1 ZBTB1 MAML3	1.18e-06	877	69	11	20211142
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HMGN5 ORC2 BPTF MYBBP1A NSD2 SUN2 MKI67 HLTF SRRM2 NIPBL CASZ1 KNOP1 SYMPK	1.37e-06	1294	69	13	30804502
Pubmed	Age-related changes in Ki-67 and DCX expression in the BALB/ c mouse (Mus Musculus) brain.	MKI67 DCX	3.88e-06	2	69	2	30472241
Pubmed	Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.	MKI67 DCX	3.88e-06	2	69	2	19710359
Pubmed	Strain-specific differences in cell proliferation and differentiation in the dentate gyrus of C57BL/6N and C3H/HeN mice fed a high fat diet.	MKI67 DCX	3.88e-06	2	69	2	18761331
Pubmed	Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers.	MKI67 DCX	3.88e-06	2	69	2	28766905
Pubmed	Differences in immunoreactivities of Ki-67 and doublecortin in the adult hippocampus in three strains of mice.	MKI67 DCX	3.88e-06	2	69	2	18649926
Pubmed	USP7 controls NGN3 stability and pancreatic endocrine lineage development.	MYBBP1A PNPLA6 MKI67 MACF1	5.55e-06	58	69	4	37117185
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GBF1 SUN2 MACF1 ARHGAP28 ATP10A MAML3 CASZ1 DCAF12	6.04e-06	493	69	8	15368895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	HMGN5 FBXO38 MYBBP1A MYCBP2 NSD2 SUN2 MKI67 PPP1R13L CDC25A SRRM2 SYMPK	6.57e-06	1049	69	11	27880917
Pubmed	Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland.	MKI67 PPARA SCD5	7.08e-06	19	69	3	16901790
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYCBP2 MKI67 LARP1 MACF1 SRRM2 CASZ1 KIF3A	7.20e-06	358	69	7	32460013
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GRIP1 GBF1 MYCBP2 LARP1 MACF1 SORBS1 BRD1 SRRM2 REEP3 SYDE1	7.46e-06	861	69	10	36931259
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	GBF1 MYCBP2 MACF1 PPP1R13L SRRM2 ATP10A FAM43A	7.61e-06	361	69	7	26167880
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	BPTF MYBBP1A MYCBP2 NSD2 SUN2 MACF1 SRRM2 DCX NIPBL KNOP1 SYMPK	8.79e-06	1082	69	11	38697112
Pubmed	A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.	MYBBP1A MYCBP2 NSD2	9.69e-06	21	69	3	24923560
Pubmed	MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.	NSD2 MAML3	1.16e-05	3	69	2	28512191
Pubmed	Stearoyl-CoA desaturase 1 deficiency reduces lipid accumulation in the heart by activating lipolysis independently of peroxisome proliferator-activated receptor α.	PPARA SCD5	1.16e-05	3	69	2	27751891
Pubmed	Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.	PPARA SCD5	1.16e-05	3	69	2	15180999
Pubmed	Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.	GRIP1 MYBBP1A	1.16e-05	3	69	2	10607837
Pubmed	Structural Analysis of the SANT/Myb Domain of FLASH and YARP Proteins and Their Complex with the C-Terminal Fragment of NPAT by NMR Spectroscopy and Computer Simulations.	GON4L NPAT	1.16e-05	3	69	2	32722282
Pubmed	A conserved interaction that is essential for the biogenesis of histone locus bodies.	GON4L NPAT	1.16e-05	3	69	2	25339177
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GON4L PACS2 MACF1 SORBS1 RERE SRRM2 SENP7	1.65e-05	407	69	7	12693553
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYBBP1A LDB1 MYCBP2 MACF1 SORBS1 PEX5L DCX ZBTB1 NIPBL KIF3A	1.96e-05	963	69	10	28671696
Pubmed	Human transcription factor protein interaction networks.	BPTF MYBBP1A LDB1 MKI67 LARP1 GON4L RERE SRRM2 ZBTB1 NIPBL SYMPK NPAT	2.23e-05	1429	69	12	35140242
Pubmed	Functional proteomics mapping of a human signaling pathway.	GRIP1 LDB1 MYCBP2 ASH1L MACF1 BRD1 PPP1R13L UHRF2	2.23e-05	591	69	8	15231748
Pubmed	De Novo Coding Variants Are Strongly Associated with Tourette Disorder.	NIPBL WWC1	2.32e-05	4	69	2	28472652
Pubmed	Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice.	PNPLA6 MKI67	2.32e-05	4	69	2	14749382
Pubmed	Transient expression of the conserved zinc finger gene INSM1 in progenitors and nascent neurons throughout embryonic and adult neurogenesis.	MKI67 DCX	2.32e-05	4	69	2	18205207
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	BPTF MYBBP1A MYLK NSD2 ASH1L LARP1 MACF1 PPARA EPX TNP1 NIPBL KNOP1	2.43e-05	1442	69	12	35575683
Pubmed	Genome-wide association study of periodontal pathogen colonization.	FBXO38 UHRF2 WWC1	3.23e-05	31	69	3	22699663
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	GAK INPP5K LARP1 PEX5L SRRM2	3.53e-05	186	69	5	33637726
Pubmed	TNIP1 is a corepressor of agonist-bound PPARs.	PPARA TNP1	3.86e-05	5	69	2	21967852
Pubmed	Ndrg2 expression in neurogenic germinal zones of embryonic and postnatal mouse brain.	MKI67 DCX	3.86e-05	5	69	2	22143493
Pubmed	Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation.	NSD2 ASH1L	3.86e-05	5	69	2	39390582
Pubmed	Neuronal Splicing Regulator RBFOX3 (NeuN) Regulates Adult Hippocampal Neurogenesis and Synaptogenesis.	MKI67 DCX	3.86e-05	5	69	2	27701470
Pubmed	p75NTR prevents the onset of cerebellar granule cell migration via RhoA activation.	MKI67 DCX	3.86e-05	5	69	2	36040414
Pubmed	An anthropoid-specific segmental duplication on human chromosome 1q22.	ASH1L GON4L	3.86e-05	5	69	2	16545939
Pubmed	Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders.	MKI67 PPP1R13L	3.86e-05	5	69	2	29352264
Pubmed	Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha.	PPARA SCD5	3.86e-05	5	69	2	18079124
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	MYBBP1A SUN2 MKI67 HLTF LARP1 RERE PPP1R13L SRRM2	4.62e-05	655	69	8	35819319
Pubmed	Development of an efficient screening system to identify novel bone metabolism-related genes using the exchangeable gene trap mutagenesis mouse models.	BPTF BRD1 REEP3	4.67e-05	35	69	3	28106071
Pubmed	The conserved Mediator subunit cyclin C (CCNC) is required for brown adipocyte development and lipid accumulation.	MKI67 PPARA SCD5	5.53e-05	37	69	3	35863637
Pubmed	Wwox deficiency leads to neurodevelopmental and degenerative neuropathies and glycogen synthase kinase 3β-mediated epileptic seizure activity in mice.	MKI67 DCX	5.79e-05	6	69	2	32000863
Pubmed	Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation.	MYLK MKI67	5.79e-05	6	69	2	26228485
Pubmed	Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.	NSD2 ASH1L	5.79e-05	6	69	2	24019522
Pubmed	DNA Methyltransferase 1 Is Indispensable for Development of the Hippocampal Dentate Gyrus.	MKI67 DCX	5.79e-05	6	69	2	27251626
Pubmed	Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation.	MAGEL2 ATP10A	5.79e-05	6	69	2	18166085
Pubmed	Structural and histone binding ability characterizations of human PWWP domains.	NSD2 BRD1	5.79e-05	6	69	2	21720545
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	MYBBP1A GBF1 MKI67 SRRM2 NIPBL	6.28e-05	210	69	5	16565220
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	MYBBP1A MKI67 LARP1 PPP1R13L SRRM2 NIPBL PSRC1	6.32e-05	503	69	7	16964243
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	MYBBP1A NSD2 MKI67 LARP1 SRRM2 KNOP1	6.89e-05	349	69	6	25665578
Pubmed	Interaction network of human early embryonic transcription factors.	BPTF LDB1 MKI67 RERE UHRF2 NIPBL	7.11e-05	351	69	6	38297188
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	GRIP1 MYO1F SORBS1 PPP1R13L WWC1	7.50e-05	218	69	5	33378226
Pubmed	Osterix is dispensable for the development of the mouse olfactory bulb.	MKI67 DCX	8.09e-05	7	69	2	27449610
Pubmed	A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice.	GBF1 LDB1	8.09e-05	7	69	2	11247667
Pubmed	Jarid2 regulates mouse epidermal stem cell activation and differentiation.	JARID2 MKI67	8.09e-05	7	69	2	21811233
Pubmed	Ganglioside GD3 is required for neurogenesis and long-term maintenance of neural stem cells in the postnatal mouse brain.	MKI67 DCX	8.09e-05	7	69	2	25297105
Pubmed	Zic2 is expressed in pluripotent cells in the blastocyst and adult brain expression overlaps with makers of neurogenesis.	MKI67 DCX	8.09e-05	7	69	2	18755297
Pubmed	The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice.	ASH1L MKI67	8.09e-05	7	69	2	28374742
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	BPTF GAK LARP1 MACF1 SRRM2 NIPBL	8.17e-05	360	69	6	33111431
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	HMGN5 BPTF MYCBP2 TOPAZ1	8.59e-05	116	69	4	21282530
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	BPTF MYBBP1A NSD2 ASH1L MKI67 SRRM2 NIPBL	9.06e-05	533	69	7	30554943
Pubmed	C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways.	MYBBP1A SUN2 LARP1 SRRM2	9.49e-05	119	69	4	35776542
Pubmed	Defining the membrane proteome of NK cells.	ORC2 MYBBP1A GAK GBF1 PNPLA6 MYCBP2 INPP5K MKI67 HLTF LARP1	9.88e-05	1168	69	10	19946888
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FBXO38 MYBBP1A GON4L MACF1 SRRM2	1.05e-04	234	69	5	36243803
Pubmed	Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.	MKI67 PPARA	1.08e-04	8	69	2	11514592
Pubmed	Development of the adult neurogenic niche in the hippocampus of mice.	MKI67 DCX	1.08e-04	8	69	2	25999820
Pubmed	Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development.	MKI67 DCX	1.08e-04	8	69	2	16777961
Pubmed	MicroRNA-582-5p Contributes to the Maintenance of Neural Stem Cells Through Inhibiting Secretory Protein FAM19A1.	MKI67 DCX	1.08e-04	8	69	2	35685988
Pubmed	A single-cell transcriptomic landscape of cadmium-hindered brain development in mice.	MKI67 DCX	1.08e-04	8	69	2	39147853
Pubmed	TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone.	MKI67 DCX	1.08e-04	8	69	2	25044744
Pubmed	Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort.	SORBS1 PPARA	1.08e-04	8	69	2	12395215
Pubmed	The ectonucleotidases alkaline phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones.	MKI67 DCX	1.08e-04	8	69	2	18031938
Pubmed	miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche.	MKI67 DCX	1.08e-04	8	69	2	19287386
Pubmed	Prenatal low-dose methylmercury exposure causes premature neuronal differentiation and autism-like behaviors in a rodent model.	MKI67 DCX	1.08e-04	8	69	2	36843845
Pubmed	Klotho regulates postnatal neurogenesis and protects against age-related spatial memory loss.	MKI67 DCX	1.08e-04	8	69	2	28837861
Pubmed	Nuclear receptor TLX regulates cell cycle progression in neural stem cells of the developing brain.	MKI67 DCX	1.08e-04	8	69	2	17901127
Pubmed	Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation.	MAGEL2 ATP10A	1.08e-04	8	69	2	23819640
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	ORC2 BPTF NSD2 NIPBL	1.11e-04	124	69	4	20850016
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ORC2 MYBBP1A GBF1 SUN2 MKI67 RERE SCD5 SRRM2 CASZ1 SYMPK	1.26e-04	1203	69	10	29180619
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	BPTF MYBBP1A MYCBP2 NSD2 MKI67 LARP1 MACF1 KNOP1	1.28e-04	759	69	8	35915203
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	MKI67 SRRM2 KNOP1 SYMPK	1.33e-04	130	69	4	35545047
Pubmed	Epitranscriptomic regulation of cortical neurogenesis via Mettl8-dependent mitochondrial tRNA m3C modification.	MKI67 DCX	1.38e-04	9	69	2	36764294
Pubmed	The Specification of Cortical Subcerebral Projection Neurons Depends on the Direct Repression of TBR1 by CTIP1/BCL11a.	MKI67 DCX	1.38e-04	9	69	2	25972180
Pubmed	TBL1XR1 Ensures Balanced Neural Development Through NCOR Complex-Mediated Regulation of the MAPK Pathway.	MKI67 DCX	1.38e-04	9	69	2	33708771
Pubmed	Auditory cortex interneuron development requires cadherins operating hair-cell mechanoelectrical transduction.	MKI67 DCX	1.38e-04	9	69	2	28705869
Pubmed	DISC1-dependent switch from progenitor proliferation to migration in the developing cortex.	MKI67 DCX	1.38e-04	9	69	2	21471969
Interaction	H3-3A interactions	HMGN5 ORC2 FBXO38 BPTF NSD2 ASH1L MKI67 HLTF BRD1 UHRF2 NIPBL CASZ1 SENP7 KNOP1 NPAT	2.20e-08	749	68	15	int:H3-3A
Interaction	H3C3 interactions	ORC2 FBXO38 BPTF NSD2 MKI67 HLTF BRD1 UHRF2 NIPBL SENP7 KNOP1 NPAT	8.82e-08	495	68	12	int:H3C3
Interaction	NUP43 interactions	BPTF NSD2 ASH1L MKI67 HLTF LARP1 GON4L ZDBF2 RERE SRRM2 NIPBL KNOP1 NPAT	1.42e-07	625	68	13	int:NUP43
Interaction	H3C1 interactions	GRIP1 HMGN5 ORC2 BPTF MYBBP1A NSD2 ASH1L MKI67 LARP1 BRD1 UHRF2 NIPBL WWC1 KNOP1	1.49e-06	901	68	14	int:H3C1
Interaction	KIF20B interactions	HMGN5 FBXO38 TOPAZ1 MKI67 UHRF2 DCAF12	1.63e-06	107	68	6	int:KIF20B
Interaction	NSD2 interactions	HMGN5 ORC2 MYBBP1A MYCBP2 NSD2 MKI67 UHRF2 KNOP1	4.28e-06	278	68	8	int:NSD2
Interaction	AR interactions	GRIP1 ORC2 MYBBP1A GAK LDB1 MYCBP2 NSD2 LARP1 RERE CDC25A ZBTB1 NIPBL CASZ1 SYMPK	4.58e-06	992	68	14	int:AR
Interaction	YWHAB interactions	GRIP1 GBF1 MYCBP2 SUN2 LARP1 PACS2 MACF1 SORBS1 BRD1 CDC25A SRRM2 REEP3 SYDE1 WWC1	5.89e-06	1014	68	14	int:YWHAB
Interaction	CBX3 interactions	HMGN5 ORC2 NSD2 MKI67 MACF1 BRD1 UHRF2 SRRM2 NIPBL SENP7 KNOP1	9.82e-06	646	68	11	int:CBX3
Interaction	HDAC1 interactions	GRIP1 BPTF MYBBP1A MYCBP2 NSD2 MKI67 GON4L ZDBF2 RERE UHRF2 ZBTB1 CASZ1 SYMPK NPAT	1.61e-05	1108	68	14	int:HDAC1
Interaction	HINFP interactions	MKI67 SRRM2 NIPBL NPAT	3.06e-05	53	68	4	int:HINFP
Interaction	MEN1 interactions	ORC2 BPTF MYBBP1A PNPLA6 SUN2 SETBP1 MKI67 LARP1 GREB1 RERE SRRM2 KNOP1 SYMPK	3.40e-05	1029	68	13	int:MEN1
Interaction	AURKB interactions	MYBBP1A GBF1 MYO1F MKI67 LARP1 MACF1 BRD1 PPP1R13L CDC25A SRRM2 KIF3A	4.45e-05	761	68	11	int:AURKB
Interaction	MRE11 interactions	HMGN5 GAK MAGEL2 GBF1 MKI67 BRD1 UHRF2	5.10e-05	287	68	7	int:MRE11
Interaction	RBBP5 interactions	HMGN5 GBF1 MKI67 HLTF RERE SRRM2 SYMPK	5.10e-05	287	68	7	int:RBBP5
Interaction	UHRF2 interactions	BPTF MYBBP1A NSD2 MKI67 UHRF2 NIPBL	5.82e-05	200	68	6	int:UHRF2
Interaction	RNF151 interactions	MYBBP1A NSD2 FAM9A SRRM2 KNOP1	5.98e-05	123	68	5	int:RNF151
Interaction	YWHAE interactions	GRIP1 GBF1 MYCBP2 LARP1 PACS2 MACF1 SORBS1 BRD1 CDC25A SRRM2 REEP3 DCX SYDE1 WWC1	6.40e-05	1256	68	14	int:YWHAE
Interaction	YWHAH interactions	GRIP1 GBF1 MYCBP2 LARP1 PACS2 MACF1 SORBS1 BRD1 CDC25A SRRM2 REEP3 SYDE1 WWC1	6.88e-05	1102	68	13	int:YWHAH
Interaction	EED interactions	HMGN5 JARID2 BPTF MYBBP1A GAK PNPLA6 MYCBP2 NSD2 SUN2 MACF1 UHRF2 SRRM2 NIPBL CASZ1 SYMPK	7.53e-05	1445	68	15	int:EED
Interaction	SFN interactions	GRIP1 GBF1 MYCBP2 LARP1 PACS2 MACF1 SORBS1 CDC25A SRRM2 REEP3	1.03e-04	692	68	10	int:SFN
Interaction	PDIA6 interactions	BPTF GBF1 MYLK MYCBP2 SUN2 MACF1 DCAF12	1.15e-04	327	68	7	int:PDIA6
Interaction	SMC5 interactions	ORC2 BPTF MYBBP1A NSD2 MKI67 LARP1 ZDBF2 SRRM2 NIPBL KNOP1 SYMPK NPAT	1.16e-04	1000	68	12	int:SMC5
Interaction	RBBP4 interactions	HMGN5 JARID2 BPTF ASH1L SRRM2 SENP7 SYMPK FAM43A NPAT	1.26e-04	573	68	9	int:RBBP4
Interaction	DSCR9 interactions	MYCBP2 ASH1L MACF1 NIPBL KIF3A	1.39e-04	147	68	5	int:DSCR9
Interaction	HDAC2 interactions	JARID2 BPTF MYBBP1A MYCBP2 NSD2 MKI67 RERE PPP1R13L SRRM2 CASZ1 SYMPK	1.40e-04	865	68	11	int:HDAC2
Interaction	CHAMP1 interactions	HMGN5 NSD2 MKI67 UHRF2 SENP7	1.43e-04	148	68	5	int:CHAMP1
Interaction	SUMO2 interactions	FBXO38 BPTF MKI67 UHRF2 SRRM2 ZBTB1 NIPBL SENP7 SYMPK	1.59e-04	591	68	9	int:SUMO2
Interaction	H2AX interactions	BPTF MKI67 HLTF GON4L BRD1 UHRF2 SRRM2 NIPBL NPAT	1.63e-04	593	68	9	int:H2AX
Interaction	SIRT7 interactions	BPTF MYBBP1A MYCBP2 NSD2 MKI67 LARP1 MACF1 SRRM2 NIPBL SYMPK	1.86e-04	744	68	10	int:SIRT7
Interaction	ZNF106 interactions	FBXO38 GAK MKI67 KNOP1	1.87e-04	84	68	4	int:ZNF106
Interaction	DNAH2 interactions	MKI67 EPX DCX	2.04e-04	34	68	3	int:DNAH2
Interaction	ZBTB21 interactions	FBXO38 LARP1 BRD1 REEP3 SYDE1	2.12e-04	161	68	5	int:ZBTB21
Interaction	FGFBP1 interactions	MYBBP1A NSD2 ASH1L MKI67 LARP1 KNOP1	2.29e-04	257	68	6	int:FGFBP1
Interaction	YWHAG interactions	GRIP1 GBF1 MYCBP2 LARP1 PACS2 MACF1 SORBS1 BRD1 CDC25A SRRM2 REEP3 SYDE1 WWC1	2.38e-04	1248	68	13	int:YWHAG
Interaction	BRCA1 interactions	HMGN5 ORC2 FBXO38 BPTF MYBBP1A GBF1 NSD2 MKI67 HLTF LARP1 BRD1 ZBTB1 NIPBL	2.40e-04	1249	68	13	int:BRCA1
Interaction	CIT interactions	ORC2 BPTF MYBBP1A ASH1L MKI67 HLTF LARP1 MACF1 CDC25A UHRF2 SRRM2 NIPBL WWC1 SYMPK	2.90e-04	1450	68	14	int:CIT
Interaction	FOXG1 interactions	ORC2 GBF1 LARP1 SYMPK	3.00e-04	95	68	4	int:FOXG1
Interaction	YWHAQ interactions	GRIP1 GBF1 MYCBP2 LARP1 PACS2 MACF1 SORBS1 BRD1 CDC25A REEP3 SYDE1 WWC1	3.26e-04	1118	68	12	int:YWHAQ
Interaction	CCNA2 interactions	ORC2 FBXO38 CDC25A UHRF2 DCX	3.84e-04	183	68	5	int:CCNA2
Interaction	MNDA interactions	MYBBP1A NSD2 MKI67 LARP1 KNOP1	4.34e-04	188	68	5	int:MNDA
GeneFamily	PHD finger proteins	BPTF NSD2 ASH1L BRD1 UHRF2	2.01e-06	90	42	5	88
GeneFamily	Doublecortin superfamily	DCLK3 DCX	2.34e-04	10	42	2	1369
GeneFamily	PWWP domain containing	NSD2 BRD1	1.18e-03	22	42	2	1147
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD2 ASH1L	2.82e-03	34	42	2	487
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GON4L RERE	6.73e-03	53	42	2	532
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	GAK GBF1 PNPLA6 MYO1F MACF1 RERE	1.43e-05	199	69	6	M9964
Coexpression	GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN	NSD2 SUN2 MKI67 ATP10A PSRC1 KNOP1	1.47e-05	200	69	6	M7143
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	FBXO38 BPTF GAK MYCBP2 MKI67 MACF1 BRD1 UHRF2 ZBTB1 MAML3 NPAT	1.64e-06	564	68	11	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	HMGN5 JARID2 BPTF NSD2 SETBP1 MKI67 ZDBF2 RERE BRD1 DCX ATP10A NIPBL PSRC1 SENP7 KNOP1	2.23e-05	1370	68	15	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500	JARID2 MAGEL2 MYLK ZDBF2 GREB1 ZBTB1 MAML3 WWC1 KNOP1	2.79e-05	496	68	9	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3	JARID2 MYBBP1A MAGEL2 MYLK GREB1 WWC1 KNOP1	3.51e-05	285	68	7	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	GRIP1 HMGN5 MAGEL2 SETBP1 MKI67 ZDBF2 DCX NIPBL MAML3 WWC1 KIF3A KNOP1	6.36e-05	989	68	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000	JARID2 MYBBP1A MAGEL2 MYLK ZDBF2 SORBS1 GREB1 ZBTB1 MAML3 WWC1 KNOP1 FAM43A	6.49e-05	991	68	12	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	BPTF GAK MKI67 MACF1 ZDBF2 BRD1 REEP3 ZBTB1 MAML3	1.13e-04	595	68	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	HMGN5 BPTF GAK MKI67 MACF1 BRD1 ZBTB1 NIPBL MAML3	1.72e-04	629	68	9	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	GRIP1 HMGN5 ASH1L MKI67 GON4L MACF1 RERE NIPBL MAML3 KIF3A	1.79e-04	780	68	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	HMGN5 JARID2 MAGEL2 SETBP1 MACF1 ZDBF2 DCX NIPBL WWC1 SENP7 KNOP1	2.77e-04	986	68	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4	GRIP1 MACF1 NIPBL WWC1	2.77e-04	98	68	4	Facebase_RNAseq_e10.5_Olfactory Pit_500_K4
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	JARID2 BPTF NSD2 GREB1 RERE MAML3	4.45e-07	186	69	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	JARID2 BPTF NSD2 GREB1 RERE MAML3	4.45e-07	186	69	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	JARID2 BPTF GREB1 RERE SRRM2 NIPBL	5.35e-07	192	69	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	BPTF NSD2 ASH1L MKI67 LARP1 SRRM2	5.35e-07	192	69	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BPTF MYCBP2 ASH1L MACF1 SRRM2 NIPBL	6.80e-07	200	69	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	BPTF MYCBP2 MACF1 SRRM2 ZBTB1 NIPBL	6.80e-07	200	69	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LPAR3 NSD2 MKI67 HLTF CDC25A	7.51e-06	174	69	5	09b091e24317c3f7bac043f04762a533e30793de
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MYLK MACF1 ARHGAP28 SORBS1 ATP10A	1.09e-05	188	69	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYLK MACF1 ARHGAP28 SORBS1 ATP10A	1.12e-05	189	69	5	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NSD2 SUN2 MKI67 CDC25A PSRC1	1.12e-05	189	69	5	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK SUN2 PACS2 PEX5L FAM43A	1.24e-05	193	69	5	947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	JARID2 BPTF RERE SRRM2 NIPBL	1.24e-05	193	69	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASH1L MACF1 SORBS1 NIPBL FAM43A	1.27e-05	194	69	5	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SUN2 SETBP1 MYO1F MACF1 ZBTB1	1.27e-05	194	69	5	24837a27b0041fe8c348225fa8b09b127d743603
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 PPARA SCD5 CASZ1 WWC1	1.27e-05	194	69	5	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L MACF1 RERE SRRM2	1.30e-05	195	69	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L MACF1 RERE SRRM2	1.30e-05	195	69	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 PPARA RERE CASZ1 WWC1	1.34e-05	196	69	5	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BPTF VASH1 ASH1L MACF1 NIPBL	1.47e-05	200	69	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	GAK NSD2 CASZ1 KIF3A	2.78e-05	112	69	4	518b7ab98b988b23f3d0f0e1f4fe90a7068f9d87
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-2\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	GREB1 RERE DCX MAML3	3.30e-05	117	69	4	94f511dbf639b164c4b096195db312ecee3ee176
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TOPAZ1 ARHGAP28 ATP10A SYDE1	9.84e-05	155	69	4	e7f49e2fdaf184fa6b4e685518004e7deff1316d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TOPAZ1 ARHGAP28 ATP10A SYDE1	9.84e-05	155	69	4	5a872ca70ae8c30b57f45a6772d7bf565e0c2663
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid\|bone_marrow / Manually curated celltypes from each tissue	GRIP1 NSD2 MKI67 PSRC1	1.50e-04	173	69	4	5645a3b1e805c71d5d65fc8e4edc4e13208063fc
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKI67 ZDBF2 SCD5 CDC25A	1.50e-04	173	69	4	6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK SETBP1 DCLK3 SORBS1	1.50e-04	173	69	4	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGN5 MKI67 MAML3 PSRC1	1.71e-04	179	69	4	5297f7459b40ca780a1983fecc1bb9c035c7677e
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYLK SETBP1 SORBS1 ATP10A	1.71e-04	179	69	4	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	MYLK SETBP1 SORBS1 ATP10A	1.71e-04	179	69	4	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 SCD5 PPP1R13L WWC1	1.79e-04	181	69	4	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SETBP1 RERE ATP10A MAML3	1.82e-04	182	69	4	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L MACF1 SRRM2	1.82e-04	182	69	4	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	MYLK ARHGAP28 SORBS1 ATP10A	1.86e-04	183	69	4	818fd886e0188091310825f9145fa53328f2c979
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP28 ATP10A MAML3 CASZ1	1.86e-04	183	69	4	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L MACF1 SRRM2	1.86e-04	183	69	4	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP28 ATP10A MAML3 CASZ1	1.86e-04	183	69	4	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	Control-T/NK_proliferative\|Control / Disease group and Cell class	TMEM169 VASH1 MKI67 PSRC1	1.86e-04	183	69	4	09c2b4e630f1c338f02c1242e3598e870d6b0a28
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L MACF1 SRRM2	1.86e-04	183	69	4	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MYLK ARHGAP28 SORBS1 ATP10A	1.86e-04	183	69	4	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MACF1 SORBS1 DCX ATP10A	1.90e-04	184	69	4	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	GBF1 NSD2 GON4L PSRC1	1.90e-04	184	69	4	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP28 ATP10A MAML3 CASZ1	1.90e-04	184	69	4	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK ARHGAP28 SORBS1 GREB1	1.90e-04	184	69	4	590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NSD2 MKI67 SCD5 CDC25A	1.94e-04	185	69	4	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5K VASH1 SYDE1 FAM43A	1.94e-04	185	69	4	60206c7322b4ddb2010040aac70561df842c9843
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 SCD5 PPP1R13L WWC1	1.94e-04	185	69	4	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGN5 MYBBP1A MKI67 SRRM2	1.98e-04	186	69	4	15ab6666748a641226e42e6ca6eeaf186a501c95
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIP1 SCD5 PPP1R13L WWC1	1.98e-04	186	69	4	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	GBF1 MYCBP2 ASH1L MACF1	1.98e-04	186	69	4	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGN5 MYBBP1A MKI67 SRRM2	1.98e-04	186	69	4	4ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L SRRM2 NIPBL	2.02e-04	187	69	4	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MYLK SETBP1 ARHGAP28 SORBS1	2.02e-04	187	69	4	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	MYLK SETBP1 MACF1 ARHGAP28	2.02e-04	187	69	4	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BPTF ASH1L SRRM2 NIPBL	2.06e-04	188	69	4	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 SETBP1 SCD5 CASZ1	2.11e-04	189	69	4	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK SETBP1 SORBS1 CASZ1	2.15e-04	190	69	4	e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BPTF MYLK MYCBP2 MACF1	2.15e-04	190	69	4	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 SETBP1 SCD5 CASZ1	2.15e-04	190	69	4	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK SETBP1 SORBS1 CASZ1	2.19e-04	191	69	4	de2cd94ee88a7754f86d39469e38374d668210c7
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK SETBP1 MACF1 ARHGAP28	2.19e-04	191	69	4	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JARID2 TMEM169 PEX5L DCX	2.24e-04	192	69	4	d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK SETBP1 MACF1 ARHGAP28	2.24e-04	192	69	4	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SETBP1 ASH1L MACF1 RERE	2.24e-04	192	69	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TSGA13 MYLK PEX5L REEP3	2.24e-04	192	69	4	8dc3016601148243196e925641c9507e9d58c9e0
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYLK MACF1 ARHGAP28 MAML3	2.24e-04	192	69	4	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGN5 NSD2 MKI67 CDC25A	2.28e-04	193	69	4	40eedc1490c113403bc7c12a6bdf976f4f8bca84
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK SETBP1 MACF1 ARHGAP28	2.28e-04	193	69	4	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK SETBP1 MACF1 ARHGAP28	2.28e-04	193	69	4	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 PPARA CASZ1 WWC1	2.28e-04	193	69	4	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BPTF MYCBP2 SETBP1 SRRM2	2.33e-04	194	69	4	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NSD2 MKI67 CDC25A PSRC1	2.37e-04	195	69	4	79ee423df85aa1631b7bdea74eacaf826dfc4a2c
ToppCell	Dividing_cells-Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NSD2 MKI67 CDC25A PSRC1	2.37e-04	195	69	4	19829760dfcc0edafd2a2bd80f424a45d039af1f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYLK MACF1 ARHGAP28 RERE	2.37e-04	195	69	4	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 RERE CASZ1 WWC1	2.37e-04	195	69	4	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRIP1 LPAR3 CASZ1 WWC1	2.37e-04	195	69	4	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRIP1 SCD5 CASZ1 WWC1	2.42e-04	196	69	4	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK SETBP1 MACF1 ARHGAP28	2.42e-04	196	69	4	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	T_cells-CTLs\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SUN2 SETBP1 MYO1F CASZ1	2.47e-04	197	69	4	28117cf300e169182571fbad0de1681a484a435a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK SUN2 PACS2 PEX5L	2.47e-04	197	69	4	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	NSD2 MKI67 CDC25A PSRC1	2.52e-04	198	69	4	b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK SUN2 PACS2 PEX5L	2.52e-04	198	69	4	bdabdb11217ea16e5863aa6bfb0f04d48b17f81e
ToppCell	erythropoietic-Basophilic_Erythroblast\|World / Lineage and Cell class	HMGN5 LDB1 HLTF UBXN10	2.52e-04	198	69	4	b3db4db02c0e659163cefb3d83f53e4940cc04bf
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	MYLK SETBP1 ARHGAP28 GREB1	2.52e-04	198	69	4	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	15-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	NSD2 SUN2 MKI67 PSRC1	2.56e-04	199	69	4	5c8b847b794b3e88722f5b841f2539a27251106c
ToppCell	Sepsis-ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, condition lineage and cell class	TSNARE1 VASH1 ZDBF2 FAM43A	2.56e-04	199	69	4	90ddd686b8f39c6f6134b9b048396cebcf8d0448
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	MYLK MKI67 MACF1 PSRC1	2.56e-04	199	69	4	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MACF1 ZDBF2 BRD1 ZBTB1	2.56e-04	199	69	4	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NSD2 MKI67 CDC25A PSRC1	2.56e-04	199	69	4	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	GRIP1 TMEM169 MYCBP2 DCX	2.61e-04	200	69	4	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYLK SETBP1 MACF1 ARHGAP28	2.61e-04	200	69	4	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related\|10w / Sample Type, Dataset, Time_group, and Cell type.	SETBP1 CASZ1 WWC1 FAM43A	2.61e-04	200	69	4	8f5d98f962ddd8c4658c89ff8a2894de1228562a
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRIP1 MAML3 CASZ1 WWC1	2.61e-04	200	69	4	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK SUN2 PACS2 PEX5L	2.61e-04	200	69	4	3ce8a2db8c25e1169a0a544f644a63104749c5ee
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK SETBP1 MACF1 ARHGAP28	2.61e-04	200	69	4	a510deaada669e690329183e18df02870bd204b3
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	BPTF MYCBP2 MACF1 SRRM2	2.61e-04	200	69	4	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	GRIP1 TMEM169 SCD5 DCX	2.61e-04	200	69	4	44bc4d6616fc8d0ad8498e56125939034e8cff01
ToppCell	3'_v3-Lung-Lymphocytic_NK-Cycling_NK\|Lung / Manually curated celltypes from each tissue	NSD2 MKI67 CDC25A PSRC1	2.61e-04	200	69	4	381bafdde6492f020ae93ab8fffa6215c631c570
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK SUN2 PACS2 PEX5L	2.61e-04	200	69	4	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK SUN2 PACS2 PEX5L	2.61e-04	200	69	4	159377d904394d91e09913131e9a93e08189955a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC\|10w / Sample Type, Dataset, Time_group, and Cell type.	SETBP1 CASZ1 WWC1 FAM43A	2.61e-04	200	69	4	345f1eac498cc87fd7bf08e7312608b2d6fe1dd7
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	BPTF LDB1 NSD2 SRRM2 ZBTB1 NIPBL SYDE1	1.32e-06	182	69	7	1951_DN
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A	BPTF GAK MKI67 MACF1 NIPBL PSRC1 NPAT	1.89e-06	192	69	7	1599_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A	NSD2 ARHGAP28 RERE BRD1 DCX SENP7 SYMPK	2.09e-06	195	69	7	6691_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	BPTF NSD2 LARP1 GREB1 SRRM2 ZBTB1	1.67e-05	178	69	6	1112_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	HMGN5 PNPLA6 INPP5K GREB1 CDC25A SYMPK	2.72e-05	194	69	6	6833_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	INPP5K SETBP1 MYO1F ASH1L ARHGAP28 RERE	2.72e-05	194	69	6	4529_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	GRIP1 PNPLA6 VASH1 BRD1 ZBTB1 SYMPK	2.80e-05	195	69	6	7033_UP
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MYLK SUN2 CDC25A SRRM2 ZBTB1 SYMPK	2.88e-05	196	69	6	3256_UP
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	HMGN5 LDB1 SUN2 RERE ZBTB1 SENP7	2.96e-05	197	69	6	2796_DN
Drug	U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A	NSD2 GON4L RERE NIPBL WWC1 SYMPK	2.96e-05	197	69	6	4553_DN
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	GBF1 VASH1 CDC25A NIPBL SYMPK NPAT	3.05e-05	198	69	6	1690_DN
Drug	(+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A	HMGN5 NSD2 GON4L SCD5 ZBTB1 NPAT	3.05e-05	198	69	6	3578_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; HL60; HT_HG-U133A	PNPLA6 LDB1 NSD2 PACS2 MACF1 SYMPK	3.14e-05	199	69	6	2331_DN
Drug	Estrogens	LPAR3 MKI67 HLTF GREB1 PPARA WWC1 FAM43A	1.14e-04	363	69	7	ctd:D004967
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF LARP1 GREB1 SRRM2 ZBTB1	1.58e-04	168	69	5	6820_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BPTF GREB1 SRRM2 ZBTB1 NIPBL	1.77e-04	172	69	5	1072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NSD2 MKI67 BRD1 SRRM2 ZBTB1	1.86e-04	174	69	5	3993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF LARP1 GREB1 ZBTB1 NIPBL	1.86e-04	174	69	5	5693_DN
Drug	Dcmp-d-guanosine	DCX SYMPK	1.88e-04	7	69	2	CID000122002
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF SETBP1 BRD1 SRRM2 ZBTB1	1.91e-04	175	69	5	6316_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF SUN2 SRRM2 ZBTB1 NIPBL	1.91e-04	175	69	5	6736_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF SUN2 LARP1 BRD1 ZBTB1	1.96e-04	176	69	5	1212_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF GREB1 BRD1 SRRM2 ZBTB1	1.96e-04	176	69	5	1535_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LARP1 GREB1 BRD1 ZBTB1 NIPBL	2.02e-04	177	69	5	6972_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NSD2 GREB1 BRD1 SRRM2 ZBTB1	2.02e-04	177	69	5	7550_DN
Drug	5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA	SUN2 INPP5K MKI67 CDC25A PSRC1	2.12e-04	179	69	5	904_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF LARP1 GREB1 SRRM2 ZBTB1	2.18e-04	180	69	5	6454_DN
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	SUN2 MKI67 CDC25A PSRC1 SYMPK	2.18e-04	180	69	5	5027_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NSD2 GREB1 BRD1 ZBTB1 NIPBL	2.24e-04	181	69	5	6951_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	BPTF MKI67 CDC25A NIPBL SYDE1	2.29e-04	182	69	5	1891_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NSD2 LARP1 GREB1 SRRM2 ZBTB1	2.35e-04	183	69	5	3510_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	JARID2 BPTF CDC25A NIPBL NPAT	2.41e-04	184	69	5	2321_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	BPTF NSD2 GREB1 BRD1 ZBTB1	2.41e-04	184	69	5	6939_DN
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	ORC2 CDC25A SRRM2 NIPBL NPAT	2.73e-04	189	69	5	7074_DN
Drug	5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA	LDB1 INPP5K GREB1 SYMPK NPAT	2.80e-04	190	69	5	961_UP
Drug	resveratrol; Down 200; 50uM; MCF7; HG-U133A	GAK MKI67 CDC25A SRRM2 PSRC1	2.80e-04	190	69	5	622_DN
Drug	17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A	VASH1 RERE CDC25A ZBTB1 SYMPK	2.87e-04	191	69	5	4437_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	PNPLA6 INPP5K VASH1 DCX SYMPK	2.87e-04	191	69	5	6959_UP
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	MYBBP1A MYLK INPP5K NIPBL NPAT	3.01e-04	193	69	5	1811_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	JARID2 PNPLA6 RERE PPP1R13L SYMPK	3.01e-04	193	69	5	3262_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	FBXO38 MYO1F ASH1L SCD5 SYMPK	3.08e-04	194	69	5	7481_DN
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	MACF1 GREB1 ZBTB1 CASZ1 WWC1	3.08e-04	194	69	5	7468_DN
Drug	5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA	INPP5K MYO1F GON4L SRRM2 SYMPK	3.08e-04	194	69	5	955_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A	HMGN5 MYLK RERE EPX SYDE1	3.08e-04	194	69	5	2258_UP
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A	FBXO38 SUN2 GON4L SORBS1 CASZ1	3.08e-04	194	69	5	5342_UP
Drug	Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A	NSD2 MKI67 SRRM2 PSRC1 KNOP1	3.08e-04	194	69	5	4617_DN
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	INPP5K SETBP1 GON4L BRD1 SYMPK	3.08e-04	194	69	5	4470_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A	BPTF MKI67 LARP1 CDC25A PSRC1	3.08e-04	194	69	5	2009_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	MYLK MYO1F SORBS1 CDC25A SYMPK	3.08e-04	194	69	5	4325_DN
Drug	Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A	HMGN5 NSD2 ARHGAP28 PPARA SENP7	3.16e-04	195	69	5	7394_UP
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	MYBBP1A PNPLA6 LARP1 PACS2 CDC25A	3.16e-04	195	69	5	1296_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A	PNPLA6 PPP1R13L CDC25A ZBTB1 SYMPK	3.16e-04	195	69	5	3269_UP
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; HL60; HG-U133A	HMGN5 BRD1 SCD5 MAML3 SYDE1	3.16e-04	195	69	5	1419_UP
Drug	(-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	GBF1 LDB1 CASZ1 SYMPK NPAT	3.16e-04	195	69	5	874_UP
Drug	Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	HMGN5 INPP5K GREB1 CDC25A SYMPK	3.16e-04	195	69	5	5277_DN
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	LDB1 INPP5K RERE CDC25A SYMPK	3.16e-04	195	69	5	2810_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	PNPLA6 MYO1F SRRM2 SYDE1 SENP7	3.16e-04	195	69	5	5241_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A	LDB1 ASH1L MKI67 GON4L CDC25A	3.16e-04	195	69	5	632_DN
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	PNPLA6 LDB1 MYLK ZBTB1 SYMPK	3.23e-04	196	69	5	6260_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A	HMGN5 SUN2 INPP5K GREB1 SCD5	3.23e-04	196	69	5	6846_DN
Drug	Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A	FBXO38 LPAR3 MKI67 GON4L CDC25A	3.23e-04	196	69	5	5724_DN
Drug	Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A	INPP5K GREB1 SYDE1 PSRC1 SYMPK	3.23e-04	196	69	5	5320_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A	HMGN5 GBF1 INPP5K MACF1 CDC25A	3.23e-04	196	69	5	5521_DN
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	INPP5K VASH1 SCD5 SRRM2 SYMPK	3.23e-04	196	69	5	7187_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	INPP5K MYO1F RERE SENP7 SYMPK	3.23e-04	196	69	5	4276_DN
Drug	Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A	NSD2 PPARA RERE CDC25A SYDE1	3.23e-04	196	69	5	3673_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	LDB1 INPP5K ASH1L BRD1 CASZ1	3.23e-04	196	69	5	6619_DN
Drug	Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A	VASH1 GREB1 PPARA EPX CDC25A	3.23e-04	196	69	5	3204_UP
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	LDB1 INPP5K PPARA RERE SCD5	3.23e-04	196	69	5	4254_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A	GAK NSD2 EPX CDC25A NPAT	3.31e-04	197	69	5	435_DN
Drug	Piperacetazine [3819-00-9]; Up 200; 9.8uM; HL60; HT_HG-U133A	LPAR3 SORBS1 ZBTB1 SYDE1 KIF3A	3.31e-04	197	69	5	6152_UP
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; HL60; HG-U133A	LPAR3 EPX CDC25A ATP10A MAML3	3.31e-04	197	69	5	1750_UP
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	HMGN5 VASH1 CDC25A SRRM2 SYMPK	3.31e-04	197	69	5	5244_DN
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	JARID2 SUN2 BRD1 SRRM2 WWC1	3.31e-04	197	69	5	4556_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	INPP5K VASH1 MYO1F GREB1 SCD5	3.31e-04	197	69	5	3270_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	MYLK ARHGAP28 PPARA RERE SRRM2	3.31e-04	197	69	5	3763_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A	MYLK INPP5K RERE EPX ATP10A	3.31e-04	197	69	5	2380_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A	ASH1L SRRM2 NIPBL SYDE1 SENP7	3.31e-04	197	69	5	1240_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	MYLK RERE EPX ATP10A SYDE1	3.38e-04	198	69	5	3612_UP
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A	HMGN5 GREB1 EPX CDC25A SYMPK	3.38e-04	198	69	5	1522_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; PC3; HT_HG-U133A	VASH1 MYO1F ARHGAP28 SORBS1 SYDE1	3.38e-04	198	69	5	5096_UP
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	LDB1 SUN2 SYDE1 WWC1 NPAT	3.38e-04	198	69	5	7204_DN
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	GBF1 SUN2 INPP5K SCD5 CDC25A	3.38e-04	198	69	5	1238_DN
Drug	Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A	FBXO38 CDC25A SRRM2 SENP7 NPAT	3.38e-04	198	69	5	1694_UP
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	GBF1 LDB1 SUN2 MYO1F ASH1L	3.38e-04	198	69	5	4788_DN
Drug	Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A	HMGN5 LDB1 PACS2 SYDE1 CASZ1	3.38e-04	198	69	5	1818_DN
Drug	Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; HL60; HG-U133A	HMGN5 JARID2 MACF1 BRD1 ATP10A	3.38e-04	198	69	5	1560_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	VASH1 PPARA SCD5 DCX ZBTB1	3.46e-04	199	69	5	4641_DN
Drug	genistein; Down 200; 1uM; MCF7; HG-U133A	LPAR3 SRRM2 ATP10A SYDE1 NPAT	3.46e-04	199	69	5	267_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NSD2 INPP5K VASH1 GON4L RERE	3.46e-04	199	69	5	4526_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	LDB1 INPP5K GREB1 CDC25A SYDE1	3.46e-04	199	69	5	3608_DN
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A	LPAR3 PNPLA6 NSD2 MACF1 SYMPK	3.46e-04	199	69	5	5509_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	MYBBP1A PNPLA6 LDB1 NIPBL NPAT	3.46e-04	199	69	5	6942_DN
Drug	Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A	LDB1 ASH1L GON4L SRRM2 SYMPK	3.46e-04	199	69	5	1702_DN
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A	LDB1 INPP5K GON4L BRD1 CDC25A	3.46e-04	199	69	5	4649_DN
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; PC3; HT_HG-U133A	LDB1 ARHGAP28 PPARA ZBTB1 WWC1	3.46e-04	199	69	5	6632_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	HMGN5 SETBP1 VASH1 RERE SRRM2	3.46e-04	199	69	5	4543_DN
Drug	1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	SUN2 GON4L SCD5 CDC25A NPAT	3.46e-04	199	69	5	1_UP
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	MYBBP1A MACF1 ARHGAP28 CASZ1 KIF3A	3.46e-04	199	69	5	5843_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A	ASH1L GON4L PACS2 SYDE1 CASZ1	3.46e-04	199	69	5	2402_DN
Disease	loneliness measurement	BPTF MACF1 RERE CDC25A SYDE1	8.80e-06	124	66	5	EFO_0007865
Disease	Intellectual Disability	BPTF NSD2 SETBP1 ASH1L GON4L PACS2 MACF1	6.30e-05	447	66	7	C3714756
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	BPTF SETBP1 MACF1 RERE MAML3 SENP7	1.65e-04	364	66	6	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	eosinophil percentage of leukocytes	BPTF PPARA RERE SCD5 UHRF2 KIF3A SYMPK FAM43A	2.53e-04	746	66	8	EFO_0007991
Disease	asthma, allergic disease	RERE UHRF2 KIF3A	7.49e-04	79	66	3	MONDO_0004979, MONDO_0005271
Disease	Parkinson disease	GAK GBF1 MYCBP2 ASH1L RERE	7.67e-04	321	66	5	MONDO_0005180
Disease	body fat percentage	BPTF SETBP1 MACF1 RERE MAML3 SENP7	7.79e-04	488	66	6	EFO_0007800
Disease	age at onset, smoking initiation	GRIP1 MYCBP2	8.22e-04	19	66	2	EFO_0004847, EFO_0005670
Disease	response to methotrexate, neurotoxicity	PNPLA6 MACF1	8.22e-04	19	66	2	EFO_0011057, GO_0031427
Disease	progranulin measurement	GRIP1 PSRC1	1.11e-03	22	66	2	EFO_0004625
Disease	Bone Diseases, Developmental	NIPBL KIF3A	1.67e-03	27	66	2	C0005941
Disease	phospholipids:total lipids ratio	BPTF MACF1 REEP3 PSRC1	1.69e-03	227	66	4	EFO_0020946

Protein segments in the cluster

Peptide	Gene	Start	Entry
MKSSGSRSKRAKLLK	BRD1	731	O95696
MKKASKGRRRLSPPT	ASH1L	1151	Q9NR48
SSPKMLQRKRKDRGG	CCDC116	371	Q8IYX3
LQRKRKDRGGSPSMS	CCDC116	376	Q8IYX3
PFGKRRKTASSRKML	CASZ1	1411	Q86V15
LMKFSRPKKTRSGTA	BPTF	1816	Q12830
RAPEKTKGKVSMRFS	ATP10A	941	O60312
MSPGRRKSESQRKST	NPAT	206	Q14207
SVSATSRPRMRKKLK	PNPLA6	126	Q8IY17
EGRTLDAKMPRKRKT	LARP1	806	Q6PKG0
TKAPEMKSRRPKSSL	MYLK	1196	Q15746
RTSSKERRAPSKDRM	MAGEL2	736	Q9UJ55
QQPSKRRKRKMSGGS	LDB1	291	Q86U70
SPTSKRIRKDISAGM	MAML3	186	Q96JK9
SEKRSPMKRERSRSH	GREB1	1111	Q4ZG55
RSVRMKRPSSVKSLR	WWC1	966	Q8IX03
GLREVKKDTRPMSRS	DCLK3	256	Q9C098
KSIKQRLRSGSASPM	EPX	56	P11678
VKSKKGSPGLTRRMS	PEX5L	431	Q8IYB4
RKKTTVSMPRSRKGD	NSD2	441	O96028
PKRTSSSRKMKTKSD	HMGN5	36	P82970
SMVKDKRKERKSSPS	NIPBL	2471	Q6KC79
GSISRRRTPMKLMKT	LPAR3	226	Q9UBY5
PSRSMESSPRKGSKK	KNOP1	231	Q1ED39
RKRTPSVGKAMDTPK	MKI67	2256	P46013
RATSGKRPSNMKRES	PSRC1	161	Q6PGN9
KPKKQRRSIVRTTSM	PACS2	231	Q86VP3
RQSLMKLERPRTSKG	KIF3A	661	Q9Y496
KSPGKRRRMLSSSDA	MACF1	1366	Q9UPN3
PSMGRKKRNRTKAKV	MYBBP1A	1206	Q9BQG0
PRHAMKRKRTADKST	FBXO38	891	Q6PIJ6
MEPVGRKRSRKAAKA	FAM9A	1	Q8IZU1
SRSDKKGPKTIAEMR	GAK	1191	O14976
MARKVVSRKRKAPAS	DCAF12	1	Q5T6F0
MSSRKLSGPKGRRLS	INPP5K	1	Q9BT40
QKTSAKSPGPMRRSK	DCX	291	O43602
PRGAKKSRLRQSSEM	GON4L	401	Q3T8J9
ALSRVGSMFRSKRKK	FAM43A	46	Q8N2R8
RDAGLVKMSRKPRAS	CSAG2	61	Q9Y5P2
KKSKEGSMLRRPRTS	GBF1	1451	Q92538
RMSELSSSRPKRRKT	HLTF	376	Q14527
STSPRGTMMRRRLKK	GRIP1	431	Q9Y3R0
EMRSVLRKAGSPRKA	PPP1R13L	606	Q8WUF5
GSTKRRKSMSGASPK	CDC25A	286	P30304
SAKKMREVRPSPSKT	JARID2	321	Q92833
IRFGRMPRSEKAKLK	PPARA	171	Q07869
TPSKRMKRDKTSDLV	ORC2	226	Q13416
RTKSPGPARRLSIKM	SYDE1	156	Q6ZW31
MDKRKLGRRPSSSEI	SENP7	1	Q9BQF6
KKKKDRGRRSESSSP	SRRM2	191	Q9UQ35
KRATKPMIEARKART	SCD5	311	Q86SK9
SKHSRSLKPDGRMSR	MYCBP2	2736	O75592
GRMSRTTADQKKPRG	MYCBP2	2746	O75592
RSRGSMSTLRSGRKK	RERE	576	Q9P2R6
RRSQSMKSVKTTKGR	REEP3	221	Q6NUK4
KKAKMPSASTESRRD	UHRF2	411	Q96PU4
MRKDASKKSASERPI	TSGA13	216	Q96PP4
GRMAGPSTTRAKKRK	TSNARE1	111	Q96NA8
RTLKRKSSNMKRLSP	SUN2	41	Q9UH99
KLKSHGMRRSKSRSP	TNP1	6	P09430
GMRRSKSRSPHKGVK	TNP1	11	P09430
KTSKVLQKSPSARRM	ARHGAP28	621	Q9P2N2
TAKRKSGSEMRPARA	SORBS1	786	Q9BX66
RMGTKGSLRVKSPSK	ZDBF2	291	Q9HCK1
RKRPRDDSDSTLKKM	SYMPK	346	Q92797
KKSGRKTLKPRMSVS	ZBTB1	381	Q9Y2K1
IEESSVGRKPRKRMK	TOPAZ1	321	Q8N9V7
MIRPKSAKGRTRPSL	UBXN10	36	Q96LJ8
TMGHRKKKRKESRPE	TMEM169	36	Q96HH4
RRPSGDKKTSEPKAM	VASH1	341	Q7L8A9
KKKRGRPAKTNDTMT	SETBP1	1016	Q9Y6X0
TRKGMAKGKPRRSSQ	MYO1F	926	O00160